Iranian Red Crescent Medical Journal

Published by: Kowsar

Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran

Mohammad Taheri 1 , Hamid Bazrafkan 2 and Mojtaba Habibagahi 2 , *
Authors Information
1 Department of Microbiology, School of Paramedical Sciences, Shiraz University of Medical Sciences, Shiraz, IR Iran
2 Immunotherapy laboratory, Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Iranian Red Crescent Medical Journal: June 5, 2013, 15 (6); 477-482
  • Published Online: June 5, 2013
  • Article Type: Research Article
  • Received: November 30, 2011
  • Revised: June 17, 2012
  • Accepted: May 8, 2013
  • DOI: 10.5812/ircmj.3635

To Cite: Taheri M, Bazrafkan H, Habibagahi M. Determining the Latent Tuberculosis Infection by IFN - γ Elispot Assay in Healthcare Workers From University Hospitals of Shiraz, South West of Iran, Iran Red Crescent Med J. 2013 ; 15(6):477-482. doi: 10.5812/ircmj.3635.

Abstract
Copyright © 2013, Iranian Red Crescent Medical Journal. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet. 2006; 368(9553): 2142-54[DOI][PubMed]
  • 2. Dye C. Global epidemiology of tuberculosis. Lancet. 2006; 367(9514): 938-40[DOI][PubMed]
  • 3. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet. 2000; 356(9235): 1099-104[PubMed]
  • 4. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med. 1999; 159(1): 15-21[DOI][PubMed]
  • 5. Ferrara G, Losi M, Fabbri LM, Migliori GB, Richeldi L, Casali L. Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection. Arch Immunol Ther Exp (Warsz). 2009; 57(6): 425-33[DOI][PubMed]
  • 6. Gey van Pittius NC, Warren RM, van Helden PD. ESAT-6 and CFP-10: what is the diagnosis? Infect Immun. 2002; 70(11): 6509-10[PubMed]
  • 7. Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 1996; 64(1): 16-22[PubMed]
  • 8. Sorensen AL, Nagai S, Houen G, Andersen P, Andersen AB. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis. Infect Immun. 1995; 63(5): 1710-7[PubMed]
  • 9. Latorre I, Altet N, de Souza-Galvao M, Ruiz-Manzano J, Lacoma A, Prat C, et al. Specific Mycobacterium tuberculosis T cell responses to RD1-selected peptides for the monitoring of anti-tuberculosis therapy. Scand J Infect Dis. 2012; 44(3): 161-7[DOI][PubMed]
  • 10. Rakotosamimanana N, Raharimanga V, Andriamandimby SF, Soares JL, Doherty TM, Ratsitorahina M, et al. Variation in gamma interferon responses to different infecting strains of Mycobacterium tuberculosis in acid-fast bacillus smear-positive patients and household contacts in Antananarivo, Madagascar. Clin Vaccine Immunol. 2010; 17(7): 1094-103[DOI][PubMed]
  • 11. Bakir M, Dosanjh DP, Deeks JJ, Soysal A, Millington KA, Efe S, et al. Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts. Clin Infect Dis. 2009; 48(3): 302-12[DOI][PubMed]
  • 12. Lucas M, Nicol P, McKinnon E, Whidborne R, Lucas A, Thambiran A, et al. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children. Thorax. 2010; 65(5): 442-8[DOI][PubMed]
  • 13. Shams H, Weis SE, Klucar P, Lalvani A, Moonan PK, Pogoda JM, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med. 2005; 172(9): 1161-8[DOI][PubMed]
  • 14. Bienek DR, Chang CK. Evaluation of an interferon-gamma release assay, T-SPOT.TB, in a population with a low prevalence of tuberculosis. Int J Tuberc Lung Dis. 2009; 13(11): 1416-21[PubMed]
  • 15. Chang KC, Leung CC. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax. 2010; 65(3): 271-6[DOI][PubMed]
  • 16. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest. 2010; 137(4): 952-68[DOI][PubMed]
  • 17. Khalili T, Nakhaee A, Salehi M, Kariminia A. A validity study of the QuantiFERON-TB Gold (QFT-TB) method for the diagnosis of pulmonary tuberculosis in a high risk population. Swiss Med Wkly. 2010; 140(5-6): 95-6[PubMed]
  • 18. Mardani M, Tabarsi P, Mohammadtaheri Z, Chitsaz E, Farokhzad B, Hadavand F, et al. Performance of QuantiFERON-TB Gold test compared to tuberculin skin test in detecting latent tuberculosis infection in HIV- positive individuals in Iran. Ann Thorac Med. 2010; 5(1): 43-6[DOI][PubMed]
  • 19. Orlando G, Merli S, Cordier L, Mazza F, Casazza G, Villa AM, et al. Interferon-gamma releasing assay versus tuberculin skin testing for latent tuberculosis infection in targeted screening programs for high risk immigrants. Infection. 2010; 38(3): 195-204[DOI][PubMed]
  • 20. Simsek H, Alpar S, Ucar N, Aksu F, Ceyhan I, Gozalan A, et al. Comparison of tuberculin skin testing and T-SPOT.TB for diagnosis of latent and active tuberculosis. Jpn J Infect Dis. 2010; 63(2): 99-102[PubMed]
  • 21. Stop TB partnership annual report 2004. 2005;
  • 22. Cimolai N. The role of healthcare personnel in the maintenance and spread of methicillin-resistant Staphylococcus aureus. J Infect Public Health. 2008; 1(2): 78-100[DOI][PubMed]
  • 23. Barsegian V, Mathias KD, Wrighton-Smith P, Grosse-Wilde H, Lindemann M. Prevalence of latent tuberculosis infection in German radiologists. J Hosp Infect. 2008; 69(1): 69-76[DOI][PubMed]
  • 24. Christopher DJ, Daley P, Armstrong L, James P, Gupta R, Premkumar B, et al. Tuberculosis infection among young nursing trainees in South India. PLoS One. 2010; 5(4)[DOI][PubMed]
  • 25. Tissot F, Zanetti G, Francioli P, Zellweger JP, Zysset F. Influence of bacille Calmette-Guerin vaccination on size of tuberculin skin test reaction: to what size? Clin Infect Dis. 2005; 40(2): 211-7[DOI][PubMed]
  • 26. Golchin M, Rostami MOSTAFA. Tuberculin test in nursing and human-sciences students. Journal of Research in Medical Sciences. 2005; 10(3): 172-76
  • 27. Girardi E, Angeletti C, Puro V, Sorrentino R, Magnavita N, Vincenti D, et al. Estimating diagnostic accuracy of tests for latent tuberculosis infection without a gold standard among healthcare workers. Euro Surveill. 2009; 14(43)[PubMed]
  • 28. Farnia P, Masjedi MR, Varahram M, Mirsaeidi M, Ahmadi M, Khazampour M, et al. The recent-transmission of Mycobacterium tuberculosis strains among Iranian and Afghan relapse cases: a DNA-fingerprinting using RFLP and spoligotyping. BMC Infect Dis. 2008; 8: 109[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments